Hereditary breast and ovarian cancer
Hereditary Breast and Ovarian Cancer Syndrome
Thematic group 3
Hereditary Breast and Ovarian Cancer syndrome (HBOC) is characterized by a high risk of breast and ovarian cancers.
Two genes are associated with the majority of HBOC families: BRCA1 and BRCA2. Other, less common genes associated with an increased risk of developing breast and other cancers, such as PTEN and TP53, are included in Thematic disease group 4 Other rare genturis.
Thematic leads
Thematic leads for HBOC in ERN GENTURIS are:
| Judith Balmaña at the Hospital Germans Trias I Pujol in Barcelona, Spain | |
|
|
Patient representatives
| Tamara Hussong Milagre, president of EVITA, Portugal | |
|
|
| Darja Molan, board member of Europa Donna Slovenia | |
|
|
| Salvo Testa, president of MUTAGENS, Italy | |
|
|
Healthcare Providers with expertise in Thematic Group 3 Hereditary Breast and Ovarian Cancer (HBOC)
|
Country |
City |
Name of Healthcare Provider |
|
Austria |
Innsbruck |
|
|
Belgium
|
Brussels |
|
|
Ghent |
||
|
Leuven |
||
|
Liege |
||
|
Czech Republic |
Brno |
|
|
Denmark |
Aarhus |
|
|
Copenhagen |
||
|
Estonia |
Tartu |
|
|
Finland |
Helsinki |
GENTURISFINSN consortium (HUS Helsinki University Hospital and OYS Oulu University Hospital) |
|
France |
Paris |
|
|
Rouen |
||
|
Germany |
Dresden |
|
|
Erlangen |
||
|
Hamburg |
||
|
Hannover |
||
|
Munich |
||
|
Hungary |
Pécs |
|
|
Italy |
Bologna |
|
|
Parma |
||
|
Rome |
||
|
Siena |
||
|
Latvia |
Riga |
|
|
Lithuania |
Vilnius |
|
|
Netherlands |
Amsterdam |
|
|
Groningen |
||
|
Leiden |
||
|
Nijmegen |
||
|
Rotterdam |
||
|
Norway |
Bergen |
|
|
Poland |
Szczecin |
Pomeranian Medical University - University Clinical Hospital no 1 |
|
Portugal |
Lisbon |
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE |
|
Porto |
||
|
Slovenia |
Ljubljana |
|
|
Spain |
Barcelona |
Hospital Germans Trias I Pujol - lnstitut Catala d'Oncologia |
|
Sweden |
Stockholm |
* These HCPs are Affiliated Partners of ERN GENTURIS